Walleye Trading’s Acceleron Pharma XLRN Stock Holding History

Walleye Trading’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-27,259	Closed	-$4.69M	–	6234
2021 Q3	$4.69M	Buy	27,259 +27,067	+14,097%	+$3.54M	0.02%	970
2021 Q2	$24K	Buy	+192	New	+$24.2K	﹤0.01%	4811
2021 Q1	–	Sell	-1,355	Closed	-$175K	–	5596
2020 Q4	$173K	Buy	+1,355	New	+$159K	﹤0.01%	3621
2020 Q3	–	Sell	-3,065	Closed	-$305K	–	4837
2020 Q2	$292K	Buy	3,065 +2,731	+818%	+$263K	﹤0.01%	2746
2020 Q1	$30K	Buy	+334	New	+$26K	﹤0.01%	3547
2019 Q2	–	Sell	-1,213	Closed	-$50.2K	–	4695
2019 Q1	$56K	Buy	1,213 +197	+19%	+$8.65K	﹤0.01%	3690
2018 Q4	$44K	Buy	+1,016	New	+$50.8K	﹤0.01%	4186

Walleye Trading's XLRN Position: Q4 2021 in Review

Walleye Trading sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 27,259 shares — an estimated $4.69M sold.

Walleye Trading first reported a position in XLRN in Q4 2018 and held it in 7 quarters. The position peaked at $4.69M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Walleye Trading reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Walleye Trading sold 27,259 Acceleron Pharma shares in Q4 2021, an estimated $4.69M.
Walleye Trading first reported a position in Acceleron Pharma in Q4 2018 and held it in 7 quarters.
Walleye Trading's Acceleron Pharma position peaked at $4.69M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Walleye Trading's 13F filing for Q4 2021, filed 14 Feb 2022.